Definitive hematopoiesis begins in the para-aortic, splanchnopleural (P-Sp) and aorta-gonad-mesonephros (AGM) regions of mouse embryos and then switches to the fetal liver [1-3]. Gene-targeted mice lacking the c-Myb transcription factor have severe hematopoietic defects in the fetal liver [4] . The role of c-Myb, if any, in P-Sp/AGM hematopoiesis has not been examined, however. Recently, we reported that oncostatin M can effectively expand both hematopoietic and endothelial-like cells from in vitro cultures of the AGM region [5] . Using this cell culture system, we examined the involvement of c-Myb in definitive hematopoiesis in the P-Sp and AGM regions. When primary cultures from the P-Sp or AGM regions of wildtype mouse embryos were probed with an anti-c-Myb antibody, hematopoietic cells but not endothelial-like cells showed positive staining. In contrast, in the P-Sp/AGM culture from c-myb -/-embryos, no hematopoietic cells were generated and endothelial-like cells predominated, indicating that the impairment of hematopoiesis in the liver of c-myb -/-embryos is actually preceded by a defect in P-Sp/AGM hematopoiesis. Hematogenic precursor cells were, however, still present in an inert but competent form among the endothelial-like, adherent cell population of c-myb -/-P-Sp/AGM cultures. When infected with a retrovirus carrying c-myb cDNA, these cultures gave rise to a significant number of hematopoietic cells. The rescued cells, unlike wild-type hematopoietic cells, were negative for c-Kit (a marker of hematopoietic progenitors), but did express other hematopoietic cell surface markers such as Mac-1, Gr-1 (myeloid markers), CD19, B220, Thy-1.2 (lymphoid markers), and Ter119 (an erythroid marker). Thus, c-Myb plays a role in the generation of hematopoietic cells in the embryonic P-Sp and AGM regions. 
Primary cultures were prepared from the P-Sp and AGM regions of wild-type mouse embryos at 9.5 and 11.5 days post coitum (dpc), respectively; as both cultures yielded identical results, we present the results for AGM cultures only. During the first few days of culture, only endothelial-like cells emerged, but these were followed by the appearance of round hematopoietic cells as described previously [5] . Figure 1a On day 7 of culture, hematopoietic cells started to detach from the cell layer and accumulated in abundance in the medium. Non-adherent hematopoietic cells were collected, cytocentrifuged and stained with Giemsa ( Figure 1c ). Cytospin samples contained blastic cells (arrow) as well as differentiated, granulocytic and macrophage-like cells (arrowhead). Upon immunostaining, the blastic hematopoietic cells (arrow) were strongly positive for c-Myb, whereas differentiated cells (arrowhead) were only weakly positive ( Figure 1d ). This observation is in agreement with previous reports showing downregulation of c-myb transcription after differentiation of hematopoietic cells [6, 7] .
Next, the AGM region from c-myb-targeted, 11.5 dpc embryos was cultured in the same manner as wild-type embryos. Heterozygous embryos were found to generate hematopoietic cells that contained a blastic cell population. The number of colony-forming units in methylcellulose cultures of these cells was equivalent to the number seen in AGM cultures from wild-type embryos (data not shown). This situation is similar to that during hematopoiesis in the fetal liver; it has been reported that the colony-forming activity in the liver is not significantly different between wild-type and c-myb +/-embryos at 14.5 dpc [8] . Thus, the amount of c-Myb protein synthesized from one allele of the gene appears to be sufficient to support definitive hematopoiesis in either the AGM region or the fetal liver.
In contrast, in AGM cultures from c-myb -/-11.5 dpc embryos, no hematopoietic cells were generated and only endothelial-like cells were observed (Figure 2a) . Similarly, neither hematopoietic cells nor colony-forming activity were detected in P-Sp cultures from c-myb -/-9.5 dpc embryos. The results clearly demonstrate that c-myb-deficient embryos are totally defective in P-Sp/AGM hematopoiesis. It therefore seems highly likely that the previously reported impairment of hematopoiesis in the liver of c-myb -/-embryos is preceded by a defect in P-Sp/AGM hematopoiesis. Phase-contrast image of (a) c-myb -/-and (b) retrovirus-infected, c-myb -/-AGM cultures. In (a), the AGM region was excised from c-myb -/-embryos at 11.5 dpc and cultured for 10 days. In (b), the AGM region was excised from c-myb -/-embryos at 11.5 dpc and cultured for 2 days before infection with a retrovirus carrying c-myb cDNA and followed by a further 10 days of culture. When AGM cultures derived from c-myb -/-11.5 dpc embryos were infected with this retrovirus, most of the adherent, endothelial-like cells expressed c-Myb in the nucleus (Figure 3c ). Interestingly, 10 days after infection, c-myb -/-AGM cultures generated a significant number of round hematopoietic cells (Figure 2b ). This was also observed in retrovirus-infected P-Sp cultures prepared from c-myb -/-9.5 dpc embryos. In addition, as a control, cmyb -/-P-Sp/AGM cultures were infected with a retrovirus lacking the c-myb insert. No hematopoietic cells were produced from these infected cultures, which were negative for c-Myb staining (Figure 3d) . The results suggest that hematogenic precursor cells are present in an inert state among the endothelial-like, adherent cell population of the c-myb -/-P-Sp/AGM cultures and that hematopoiesis can be rescued by forced expression of c-myb. Another possibility that cannot be excluded, though, is that a small number of hematopoietic progenitors distinct from endothelial-like cells remain in the initial cultures of c-myb -/-P-Sp/AGM region.
The rescued hematopoietic cells expressed c-Myb protein and transcribed the β-major globin gene, a marker of adulttype erythrocytes (data not shown). Most of the rescued hematopoietic cells were, however, morphologically differentiated and few blastic cells could be identified (Figure 2c ). We therefore subjected the virus-infected AGM cultures from 11.5 dpc c-myb -/-embryos to analysis by flow cytometry with mixtures of antibodies (Figure 4b ). The cells were positive for the myeloid markers Mac-1 and/or Gr-1; the lymphoid markers B220, CD19 and/or Thy-1.2; an erythroid marker Ter119; and a marker of hematopoietic cells (except for erythrocytes) CD45. The flow-cytometric profiles were similar to those of hematopoietic cells from wild-type AGM cultures (Figure 4a) . The rescued cells were, however, negative for c-Kit, whereas wild-type cells expressed this marker. In addition, the rescued hematopoietic cells from c-myb -/-cultures were unable to form colonies of mixed type such as CFU-GEMM on methylcellulose media (Table 1) , indicating the absence of multipotent progenitors. Virusinfected, c-myb -/-cultures from the 9.5 dpc P-Sp region produced no CFU-GEMM activity, either. These results suggest that forced c-myb expression can induce the generation of hematopoietic cells in c-myb -/-P-Sp/AGM cultures but the experimental conditions we employed in this study were not sufficient for the rescue of hematopoietic progenitors at a detectable level.
This study provides conclusive evidence that c-Myb expression correlates with and is essential for the generation of hematopoietic cells from the P-Sp/AGM region of mouse embryos. This conclusion is in accordance with a previous report showing that embryonic stem cells become committed to the hematopoietic lineage, if they constitutively express the c-myb gene [9] . Thus, the c-myb gene seems likely to control the generation of hematopoietic cells in the P-Sp/AGM region, the site of initiation of definitive hematopoiesis.
As oncostatin M is absolutely required for efficient production of hematopoietic as well as endothelial-like cells in the AGM culture, we postulated the existence of common precursor cells for both lineages [5] . The existence of hematogenic endothelial cells or hemangioblasts is supported by a number of studies employing various approaches [10] [11] [12] [13] [14] [15] . Hematogenic precursor cells whose proliferation and/or differentiation was blocked in c-myb -/-P-Sp/AGM cultures Brief Communication 835 
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Supplementary materials and methods
Tissue culture
The P-Sp and AGM regions were excised at 9.5 and 11.5 dpc, respectively, from C57BL/6 or c-myb-targeted embryos and trypsinized as previously described [S1]. Targeting of the c-myb gene was performed as described [S2] . Cells were suspended in Dulbecco's modified Eagle's medium supplemented with 15% (v/v) fetal calf serum, 100 ng/ml stem-cell factor (Kirin Brewery), 1 ng/ml basic fibroblast growth factor (Gibco BRL), 10 ng/ml leukemia inhibitory factor (R&D Systems) and 10 ng/ml oncostatin M (R&D Systems). As essentially identical results were obtained for both the 9.5 and 11.5 dpc cultures, we have shown only the data obtained for the 11.5 dpc culture.
Immunohistochemistry
Fixing, immunoreaction and washing procedures were performed as described previously [S3] . The primary and secondary antibodies used were anti-c-Myb peptide antibody (M19, Santa Cruz Biotechnology) and biotin-conjugated anti-rabbit IgG antiserum (Vector Laboratories), respectively. In a preabsorption experiment, 1 ml 80-fold diluted anti-cMyb peptide antibody was incubated with 10 µg peptide on ice for 60 min prior to use in immunostaining.
Immunoblot analysis
Protein was extracted from the cells as described elsewhere [S3] . Protein (20 µg) was separated by electrophoresis on an SDS-8% (w/v) polyacrylamide gel. Transfer of the protein from the gel onto the filter, the blocking reaction, incubation of the filter with anti-c-Myb antibody and visualization of the immunocomplexes using ABC kit and ECL detection reagents were performed as described [S4] .
Flow cytometry
The monoclonal antibodies used in flow cytometry were FITC-conjugated anti-Mac-1 (M1/70), anti-Gr-1 (RB6-8C5), anti-Thy-1.2 (30-H12), anti-B220 (RA3-6B2), anti-CD19 (1D3), anti-Ter119 (Ter119) and anti-c-Kit (3C1) antibodies. Anti-Flk-1 (Avas12a1), anti-PECAM-1 (MEC13.3) and anti-human granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor [S5] antibodies were not conjugated with fluorescein. The secondary antibodies were FITC-conjugated antirat IgG to detect Flk-1 and PECAM-1, and FITC-conjugated anti-mouse IgG to detect human GM-CSF receptor. All of the antibodies except for anti-human GM-CSF receptor were purchased from Pharmingen. Flow cytometry procedures were carried out as previously described [S6] .
Expression profiles of endothelial-cell markers
The adherent cell population was harvested from c-myb +/+ and c-myb -/-AGM cultures and subjected to flow cytometric analysis ( Figure S1 ). The antibodies used were against Flk-1 and PECAM-1. Diacetylated low-density lipoprotein (DiI-Ac-LDL) incorporation assays were carried out as previously described [S6] . Expression of these endothelial cell markers did not vary significantly between the two c-myb genotypes.
Retrovirus infection of cells
The murine c-myb cDNA was inserted into a pMx vector [S7] . BOSC23 cells for packaging ecotropic retrovirus were plated the night before transfection. Transient transfection of BOSC23 cells with plasmid DNA was performed using Lipofectamine Reagent (Gibco BRL). The cells were incubated for 48 h and the supernatant was collected and used immediately for infection. The growth medium was aspirated from PSp/AGM cultures and the viral supernatant was added together with 10 µg/ml polybrene (Sigma) and cytokines as described above. After incubation for 24 h, the virus-containing medium was replaced with standard growth medium.
Monitoring the efficiency of retrovirus infection
A cDNA encoding human GM-CSF receptor was packaged in the retrovirus system as described above. AGM cultures prepared from c-myb +/+ and c-myb -/-11.5 dpc embryos were infected with this virus. After incubation for 24 h, the cells were analyzed by flow cytometry using the anti-GM-CSF receptor antibody ( Figure S2 ). The percentages of fluorescence-positive cells were 46 and 36, respectively, for the c-myb +/+ and c-myb -/-cultures. No hematopoietic cells were produced from the c-myb -/-cultures even after prolonged incubation.
Colony-forming unit of colonies (CFU-C) assay
These were performed as described elsewhere [S6] . Ten thousand hematopoietic cells from a P-Sp/AGM culture were incubated in 1 ml culture medium containing α-MEM, 0.8% (w/v) methylcellulose, 30% (v/v) fetal calf serum, 1% (w/v) deionized bovine serum albumin, 100 µM 2-mercaptoethanol, 10 ng/ml IL-3 [S8] , 100 ng/ml IL-6 (Ajinomoto), 2 U/ml erythropoietin (Kirin Brewery) and 100 ng/ml stem-cell factor. Numbers of colonies were scored on the fourteenth day of culture.
Figure S1
Expression profiles of endothelial-cell markers in AGM cultures. 
